Gastric Acid Secretion and Fasting Serum Gastrin in Patients with Duodenal Ulcer, Prepyloric Ulcer or Gastric Ulcer

1982 ◽  
Vol 14 (3) ◽  
pp. 231-235 ◽  
Author(s):  
H. Stødkilde-Jørgensen ◽  
N.A. Løvgreen ◽  
J. Ørnsholt ◽  
E. Amdrup
Keyword(s):  
Duodenal Ulcer ◽  
Gastric Ulcer ◽  
Acid Secretion ◽  
Gastric Acid Secretion ◽  
Gastric Acid ◽  
Serum Gastrin ◽  
Fasting Serum ◽  
Prepyloric Ulcer

Effect of histamine H-receptor blockade on fasting serum gastrin and fasting gastric acid secretion in the dog

Nature ◽  
1974 ◽  
Vol 249 (5458) ◽  
pp. 666-668 ◽  
Author(s):  
G. O. BARBEZAT ◽  
M. DANIEL ◽  
S. BANK ◽  
B. GRANT ◽  
A. VINIK
Keyword(s):  
Acid Secretion ◽  
Gastric Acid Secretion ◽  
Gastric Acid ◽  
Serum Gastrin ◽  
Receptor Blockade ◽  
Fasting Serum

Cimetidine

1979 ◽  
Vol 17 (8) ◽  
pp. 29-32
Keyword(s):  
Duodenal Ulcer ◽  
Gastric Ulcer ◽  
Acid Secretion ◽  
Receptor Antagonist ◽  
Gastric Acid Secretion ◽  
Gastric Acid ◽  
Reflux Oesophagitis ◽  
Benign Gastric Ulcer ◽  
Zollinger Ellison Syndrome ◽  
Stomal Ulceration

Cimetidine (Tagamet - SKF) is the first histamine-H2 receptor antagonist in general use. It reduces gastric acid secretion and is marketed for the treatment of duodenal ulcer, benign gastric ulcer, recurrent and stomal ulceration, reflux oesophagitis and Zollinger-Ellison syndrome.

Sign in / Sign up

Export Citation Format

Share Document